Cerebral Thrombectomy Systems Market to Experience Significant Growth During the Forecast 2023-2030
Cerebral Thrombectomy Systems Market
Overview:
The cerebral
thrombectomy systems market Research Report refers to the industry
dedicated to the development, manufacturing, and distribution of medical
devices used in the treatment of acute ischemic stroke. Acute ischemic stroke
occurs when a blood clot blocks an artery in the brain, leading to a sudden
interruption of blood flow and potentially causing severe damage. Cerebral
Thrombectomy Systems Market Size was valued at USD 3,816.57 Million in 2022 and
is projected to reach USD 5,707.43 Million by 2030, growing at a CAGR of 5.2%
during the forecast period.
Cerebral
thrombectomy systems play a crucial role in the management of acute ischemic
stroke. These systems are designed to be inserted into the affected blood
vessels, allowing physicians to navigate through the arterial network and reach
the site of the clot. Once in position, the system employs various mechanisms,
such as stent retrievers or suction devices, to capture and remove the clot.
Market Definition:
Cerebral
thrombectomy systems are specialized medical devices designed to remove blood
clots from the cerebral arteries, restoring blood flow to the affected brain
regions. These systems utilize minimally invasive techniques, such as
mechanical thrombectomy, to retrieve clots effectively and restore blood
circulation. With the ability to rapidly restore blood flow, cerebral
thrombectomy systems have revolutionized the treatment of acute ischemic
stroke.
Market Drivers:
The
increasing prevalence of acute ischemic stroke worldwide is a major driver for
the cerebral thrombectomy systems market. Factors such as an aging population,
sedentary lifestyles, and the growing prevalence of risk factors like
hypertension and diabetes contribute to the higher incidence of stroke. As the
number of stroke cases continues to rise, the demand for effective treatment options,
including cerebral thrombectomy systems, increases.
There is a
growing awareness among healthcare professionals and the general population
about the benefits of thrombectomy in stroke treatment. Cerebral thrombectomy
systems have demonstrated significant success in restoring blood flow to the
brain and improving patient outcomes. This increased awareness has led to a
higher adoption rate of these systems, driving the market growth.
Browse In-Depth: To Know More
about Cerebral Thrombectomy Systems Market Report:
Market Challenges:
The cerebral
thrombectomy systems market is subject to rigorous regulatory requirements
imposed by authorities such as the U.S. Food and Drug Administration (FDA) and
the European Medicines Agency (EMA). Obtaining regulatory approvals for new
devices or making modifications to existing ones can be a lengthy and costly
process. Adhering to these strict regulations poses a significant challenge for
manufacturers and may impact the speed of bringing new products to market.
Cerebral
thrombectomy systems and associated equipment involve high upfront costs for
healthcare providers. These costs can include the purchase of the devices, training
of medical professionals, and investment in advanced imaging equipment. The
financial burden associated with adopting and maintaining these systems may
hinder their widespread adoption, particularly in regions with limited
healthcare resources.
Market Segmentation:
By Product Type
Enveloping Coils: Enveloping coils are used in
cerebral thrombectomy procedures to promote clot removal by deploying a coil
within the clot to induce thrombus organization and facilitate blood flow
restoration.
Rheolytic Devices: Rheolytic devices utilize
high-pressure jets of saline solution to fragment and remove blood clots in the
cerebral arteries, restoring blood flow.
Laser-based Devices: Laser-based devices employ laser
energy to dissolve or break down blood clots in the cerebral arteries, allowing
for their removal.
Suction Devices: Suction devices are designed to
create negative pressure to aspirate or suction out blood clots from the
affected cerebral arteries, facilitating blood flow restoration.
Catheters with Balloons: Catheters with balloons are used in
cerebral thrombectomy procedures to navigate through the blood vessels and
deploy a balloon to help occlude the blood flow, enabling clot removal.
Snares: Snares are specialized devices with a
looped wire that can be deployed to ensnare and retrieve blood clots from
cerebral arteries.
By End Users:
Hospitals: Hospitals are the primary end-users
of cerebral thrombectomy systems. They provide specialized stroke care units or
neurovascular departments where these systems are utilized for acute ischemic
stroke treatment.
Clinics: Clinics, including specialty clinics
and neurovascular centers, play a crucial role in providing stroke care and may
utilize cerebral thrombectomy systems for treatment. These clinics may offer specialized
care and interventions for stroke patients.
Ambulatory Centers: Ambulatory centers, such as
ambulatory surgical centers, provide outpatient care and perform surgical
procedures, including cerebral thrombectomy, outside of traditional hospital settings.
They offer a convenient and cost-effective alternative for certain patient
populations.
Academic Research Centers: Academic research centers focus on
research, innovation, and the advancement of medical knowledge. They may
utilize cerebral thrombectomy systems for research purposes or in clinical
trials to evaluate their efficacy and develop new treatment approaches.
Key players Of the Cerebral
Thrombectomy Systems Market
The cerebral
thrombectomy systems market is highly competitive and characterized by the
presence of several prominent players. These key players are continuously engaged
in Dynamics and cerebral
thrombectomy systems development activities to enhance the efficacy and
safety of their products. Some of the leading companies operating in this
market include:
·
Penumbra Inc.
·
Terumo Medical Corporation
·
Medical Devices Business Services
Inc. (Johnson & Johnson)
·
Stryker
·
Abbott
·
Boston Scientific Corporation
·
Medtronic
·
Teleflex Incorporated
·
Cardiovascular Systems Inc.
·
Angio Dynamics
Regional Analysis:
North
America, comprising the United States and Canada, holds a significant share in
the cerebral thrombectomy systems market. The region benefits from a
well-established healthcare infrastructure, advanced medical technology, and
high awareness about stroke treatment. Europe, including countries such as the
United Kingdom, Germany, France, and Spain, is a prominent market for cerebral
thrombectomy systems. The region has a high prevalence of stroke, driving the
demand for effective treatment options like thrombectomy systems.
The Asia
Pacific region, encompassing countries like China, Japan, India, and South
Korea, is witnessing significant growth in the cerebral thrombectomy systems
market. The region has a large patient population, increasing healthcare
expenditure, and improving healthcare infrastructure, which creates opportunities
for market expansion. Latin
American countries, including Brazil and Mexico, are emerging markets for
cerebral thrombectomy systems. Increasing awareness about stroke treatment,
improved access to healthcare facilities, and growing healthcare infrastructure
are driving market growth in the region.
Recent Developments:
Medtronic's Breakthrough Technology
in Thrombectomy Systems (2021): In 2021, Medtronic, a leading medical technology company,
introduced a breakthrough technology called the Arc Catheter System for
mechanical thrombectomy. The Arc Catheter System offers improved navigation and
clot engagement capabilities, enhancing the efficiency of thrombectomy
procedures. This development showcases Medtronic's commitment to advancing
stroke treatment and improving patient outcomes.
Stryker's Launch of the Trevo XP
ProVue Retriever (2022): In 2022, Stryker, a global medical technology company, launched the
Trevo XP ProVue Retriever for ischemic stroke treatment. The Trevo XP ProVue
Retriever is an innovative stent retriever device that allows physicians to
visualize the clot during the thrombectomy procedure. The enhanced
visualization capability helps optimize clot removal and improve patient
outcomes.
About CBI
Consegic Business Intelligence Pvt
Ltd. is the leading research industry that offers
contextual and data-centric research services to its customers across the
globe. The firm assists its clients to strategize business policies and
accomplish sustainable growth in their respective market domains. The industry
provides consulting services, syndicated research reports, and customized
research reports.
Topnotch research organizations and institutions to
comprehend the regional and global commercial status use the data produced by
Consegic Business Intelligence Pvt Ltd. Our reports comprise in-depth
analytical and statistical analysis on various industries in foremost countries
around the globe.
Contact us:
Consegic Business intelligence Pvt
Ltd.
Email: sales@consegicbusinessintelligence.com
Other Related Reports:
https://www.consegicbusinessintelligence.com/bovine-colostrum-market
https://www.consegicbusinessintelligence.com/artificial-tears-market
https://www.consegicbusinessintelligence.com/cardiac-medical-device-market
https://www.consegicbusinessintelligence.com/chemotherapy-devices-market
Comments
Post a Comment